Induction Quadruplet Therapy and Minimal/Measurable Residual Disease (MRD)-Informed Treatment Adaptation in Newly Diagnosed Multiple Myeloma (NDMM): Results from an Academic-Community Pathway

被引：1
|
作者：
Ravi, Gayathri [1 ]
Giri, Smith [2 ]
Bal, Susan [3 ]
Godby, Kelly N. [4 ]
Reddy, Vishnu V. B. [5 ]
Salzman, Donna [6 ]
Alkharabsheh, Omar [7 ]
McDaniel, Scott A. [8 ]
Sentell, Melissa [6 ]
Costa, Luciano J. [9 ]
机构：
[1] Univ Alabama Birmingham, Dept Med, Div Hematol Oncol, Birmingham, AL 35294 USA
[2] Univ Alabama Birmingham, Inst Canc Outcomes & Survivorship, Birmingham, AL USA
[3] Univ Alabama Birmingham, ONeal Comprehens Canc Ctr, Birmingham, AL USA
[4] Univ Alabama Birmingham, Dept Med, Div Hematol Oncol, Birmingham Hosp, Birmingham, AL USA
[5] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA
[6] Univ Alabama Birmingham, Birmingham, AL USA
[7] Univ S Alabama, Mitchell Canc Inst, Mobile, AL USA
[8] Alabama Oncol Hematol Associates, Montgomery, AL USA
[9] Univ Alabama, Birmingham Hosp, Vestavia, AL USA
来源：
BLOOD | 2022年 / 140卷
关键词：
D O I：
10.1182/blood-2022-170099
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：8048 / 8049
页数：2
相关论文
共 50 条
  • [1] Immune Profiling of Newly Diagnosed Multiple Myeloma (NDMM) Treated with Quadruplet Induction and Autologous Stem Cell Transplantation (ASCT) and Comparison with Achievement of Minimal Residual Disease (MRD) Negativity
    Bal, Susan
    Zumaquero, Esther
    Ravi, Gayathri
    Godby, Kelly
    Giri, Smith
    Denslow, Ashley
    Perez, Joaquin Bauta
    Zhou, Fen
    Chen, Suki
    Padilla, Megan
    Siddiqui, Amna
    Ubersax, Clare
    Hornsby, Erin
    Costa, Luciano
    Lund, Frances E.
    BLOOD, 2023, 142
  • [2] Humoral immune reconstitution after quadruplet therapy, autologous hematopoietic cell transplant (AHCT) and measurable residual disease adapted treatment cessation in newly diagnosed myeloma (NDMM)
    Gowda, Sonia
    Silbermann, Rebecca
    Schmidt, Timothy
    Dhakal, Binod
    Bal, Susan
    Biltibo, Eden
    Chhabra, Saurabh
    Dholaria, Bhagirathbhai
    Giri, Smith
    Godby, Kelly
    Medvedova, Eva
    Callander, Natalie
    Costa, Luciano
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S15 - S16
  • [3] Upfront or Deferred Autologous Stem Cell Transplantation for Newly Diagnosed Multiple Myeloma in the Era of Triplet and Quadruplet Induction and Minimal Residual Disease/Risk-Adapted Therapy
    Mo, Clifton C.
    Hartley-Brown, Monique A.
    Midha, Shonali
    Richardson, Paul G.
    CANCERS, 2023, 15 (24)
  • [4] MINIMAL RESIDUAL DISEASE (MRD) BY MULTIPARAMETER FLOW CYTOMETRY (MFC) AND NEXT-GENERATION SEQUENCING (NGS) IN NEWLY DIAGNOSED TRANSPLANT-ELIGIBLE MULTIPLE MYELOMA (NDMM): RESULTS FROM THE FORTE TRIAL
    Oliva, S.
    Genuardi, E.
    Rota-Scalabrini, D.
    Zamagni, E.
    Auclair, D.
    Jacob, A. P.
    Zambello, R.
    Spadano, A.
    Giuliani, N.
    Cuoghi, A.
    De Rosa, L.
    Visca, L.
    Gozzetti, A.
    Pietrantuono, G.
    Patriarca, F.
    de Fabritiis, P.
    Aquino, S.
    Kirsch, I. R.
    Offidani, M.
    Belotti, A.
    Musto, P.
    Boccadoro, M.
    Gay, F.
    HAEMATOLOGICA, 2021, 106 (10) : 74 - 74
  • [5] Treatment Journeys of Patients With Newly Diagnosed Multiple Myeloma (NDMM): Results From The Connect MM Registry
    Jagannath, Sundar
    Rifkin, Robert M.
    Gasparetto, Cristina J.
    Toomey, Kathleen
    Durie, Brian G. M.
    Hardin, James W.
    Terebelo, Howard R.
    Wagner, Lynne
    Narang, Mohit
    Ailawadhi, Sikander
    Omel, James L.
    Srinivasan, Shankar
    He, Mia
    Ung, Brian
    Kitali, Amani
    Flick, E. Dawn
    Agarwal, Amit
    Abonour, Rafat
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 (05): : 272 - 276
  • [6] A Phase 2 Study with Minimal Residual Disease (MRD) Driven Adaptive Strategy in Treatment for Newly Diagnosed Multiple Myeloma with Upfront Daratumumab-Based Therapy
    Ye, J. Christine
    Boonstra, Philip S.
    Boyer, Daniel F.
    Anderson, Larry D.
    Lipe, Brea C.
    Kin, Andrew
    Campagnaro, Erica L.
    Pianko, Matthew J.
    Talpaz, Moshe
    BLOOD, 2019, 134
  • [7] Preliminary Results of Daratumumab, Cyclophosphamide, Thalidomide and Dexamethasone: A Quadruplet Intensified Treatment for Newly Diagnosed Multiple Myeloma (NDMM) Transplant Eligible (TE) Patients
    Crusoe, Edvan De Queiroz
    Salvino, Marco Aurelio
    Silva, Sarah Queiroz
    Santos, Herbert Henrique de Melo
    Santos, Allan de Souza
    Almeida, Alessandro de M.
    Vieira, Lucas de Oliveira
    Fonseca, Cleverson Alves
    Lucas, Larissa Ferreira
    Leal, Joanna
    Santos, Mariane Melo
    Santos, Juliana Andrade
    Adorno, Elisangela
    Hungria, Vania T. M.
    Arruda, Maria da Gloria B.
    BLOOD, 2020, 136
  • [8] Predictors and MRD-Driven Treatment Strategies of Unsustained Measurable Residual Disease Negativity in Transplant-Eligible Patients with Newly Diagnosed Multiple Myeloma
    Li, Xiaozhe
    Li, Juan
    BLOOD, 2024, 144 : 4710 - 4710
  • [9] Daratumumab (Dara), Cyclophosphamide, Thalidomide and Dexamethasone: a quadruplet intensified treatment for transplant eligible newly diagnosed Multiple Myeloma (TE NDMM) patients final results
    Crusoe, Edvan
    Santos, Juliana
    Leal, JOanna
    Santos, Herbert
    Santos, Allan
    Almeida, Alessandro
    Santos, Mariane
    Lucas, Larissa
    Queiroz, Sarah
    Fonseca, Cleverson
    Adorno, Elisangela
    Vieira, Lucas
    Hungria, Vania
    Salvino, Marco
    Arruda, Maria da Gloria
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S130 - S130
  • [10] Minimal Residual Disease (MRD) Detection By Deep Sequencing In Newly Diagnosed Multiple Myeloma Patients Treated With Carfilzomib, Lenalidomide and Dexamethasone
    Mailankody, Sham
    Korde, Neha
    Faham, Malek
    Kwok, Mary
    Manasanch, Elisabet E.
    Bhutani, Manisha
    Tageja, Nishant
    Kazandjian, Dickran
    Weng, Li
    Moorhead, Martin
    Costello, Rene
    Zhang, Yong
    Zingone, Adriana
    Burton, Debbie
    Wu, Peter
    Mulquin, Marcia
    Zuchlinski, Diamond
    Kurlander, Roger
    Maric, Irina
    Calvo, Katherine R.
    Braylan, Raul C.
    Yuan, Constance
    Stetler-Stevenson, Maryalice
    Arthur, Diane C.
    Roschewski, Mark
    Landgren, Ola
    BLOOD, 2013, 122 (21)
12345